Clinical trial
Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy
NCT00123279 · ThromboGenics, Industry · Completed
Key facts
| NCT number | NCT00123279 |
|---|---|
| Title | Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy |
| Official title | A Dose-escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy |
| Lead sponsor | ThromboGenics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vitreomacular Traction Maculopathy, Eye Diseases |
| Intervention type | Drug |
| Interventions | Microplasmin |
| Enrollment | 60 |
| Start date | Dec 1, 2004 |
| Primary completion | Feb 1, 2007 |
| Completion | Nov 1, 2008 |
| First posted | Jul 22, 2005 |
| Last update posted | Apr 7, 2014 |
| Countries | Belgium, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: